Risks of Ozempic, Wegovy, and Mounjaro for Children: Expert Warnings
Experts are warning against prescribing weight-loss drugs like Ozempic, Wegovy, and Mounjaro to children, citing potential risks of abuse, malnutrition, and body dysmorphia. While the American Academy of Pediatrics recommends using these drugs as part of a weight-loss regimen for children aged 12 and older, researchers from the University of California at Irvine express concerns about the long-term effects on children's physical and mental development. They highlight the importance of balanced caloric intake and physical activity for growth and bone health, and caution against the potential impact on self-esteem and body image during adolescence. The researchers also raise concerns about the potential for abuse, particularly among those with eating disorders or involved in sports that emphasize body weight. Longitudinal research is needed to assess the safety and efficacy of these drugs in children.
